CASE REPORT
Miliary tuberculosis as a complication of untreated AIDS: a case report
More details
Hide details
1
Department of Infectious Diseases, Liver Disease, and Acquired Immune Deficiencies, Wroclaw Medical University, Poland
2
Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Poland
3
1st Department of Infectious Diseases, Jerzy Gromkowski Regional Specialist Hospital, Wroclaw, Poland
Submission date: 2024-09-11
Final revision date: 2024-10-22
Acceptance date: 2024-11-08
Online publication date: 2025-05-05
Corresponding author
Hubert Ciepłucha
Department of Infectious Diseases, Liver Diseases and Acquired
Immune Deficiencies, Wroclaw Medical University,
1 Wybrzeże Ludwika Pasteura, 50-367 Wroclaw, Poland
HIV & AIDS Review 2025;24(2):158-161
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Miliary tuberculosis (TB) is the most common bacterial opportunistic infection in patients with advanced stage of acquired immunodeficiency syndrome, particularly in those not undergoing antiretroviral therapy (ART). The described patient was admitted to the infectious diseases ward due to disseminated TB affecting multiple organs.
Case description:
The patient was diagnosed with human immunodeficiency virus (HIV) infection 20 years ago, and initially received ART with good results. However, due to discontinuing ART for several years resulting in significant immunosuppression, the patient developed pulmonary TB at the end of 2020. Initial treatment was effective, but six months later, there was a recurrence in the form of severe miliary TB. The patient's condition was critical upon admission. Antituberculosis treatment and ART were applied, leading to an improvement in his condition. A year after Mycobacterium tuberculosis infection, follow-up renal function test revealed permanent kidney damage.
Conclusions:
This case highlights the importance of strict adherence to medical recommendations and consistent intake of ART. In the case of HIV/TB co-infection, attention should be given to efficient infection diagnosis and prompt initiation of antituberculosis treatment and ART. Severe opportunistic infections in HIV-infected patients can lead to chronic kidney diseases, which should be considered when planning the continuation of ART.
REFERENCES (17)
2.
Philipose C, Sinchana KM, Haridas H, Ramapuram J, Rai S. Clinico-pathological profile of patients with HIV and tuberculosis co-infection. HIV AIDS Rev 2024; 23: 204-208.
3.
Gebreyes DE. A survival analysis of prognostic determinant factors of time-to-death of HIV/TB co-infected patients under HAART followed-up in a public hospital in Ethiopia. HIV AIDS Rev 2023; 22: 110-130.
4.
Sharafi M, Mirahmadizadeh A, Hassanzadeh J, Seif M. Identifying latent class of risk factors among HIV patients in Iran: results from national HIV/AIDS surveillance data. HIV AIDS Rev 2024; 23: 29-36.
6.
Frey V, Phi Van VD, Fehr JS, Ledergerber B, Sekaggya-Wiltshire C, Castelnuovo B, et al. Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS. Medicine (Baltimore) 2023; 102: e32917. DOI: 10.1097/MD.0000000000032917.
7.
Solomon A, Feldman C, Kobilski SA. Abdominal findings in AIDS-related pulmonary tuberculosis correlated with associated CD4 levels. Abdom Imaging 1998; 23: 573-577.
8.
Parczewski M, Witak-Jędra M, Aksak-Wąs B. Zasady opieki nad osobami zakażonymi HIV. Zalecenia PTN AIDS 2023. Warszawa-Szczecin: Polskie Towarzystwo Naukowe AIDS; 2023.
9.
Kamali M, Navaeifar MR, Abbaskhanian A, Hajialibeig A, Godazandeh F, Salehpour M, Rezai MS. Unusual presentation of miliary tuberculosis in a 12-year-old girl: a case report. BMC Pediatr 2024; 24: 223. DOI: 10.1186/s12887-023-04427-x.
10.
Libraty DH, Byrd TF. Cutaneous miliary tuberculosis in the AIDS era: case report and review. Clin Infect Dis 1996; 23: 706-710.
11.
Kujur N, Chandra Sugatha Rao S, Rajagopalawarrier B. Posterior fossa tuberculosis: unusual presentations of a common disease and literature review. World Neurosurg X 2024; 23: 100329. DOI: 10.1016/j.wnsx.2024.100329.
12.
Korzeniewska-Koseła M, Grzelewska-Rzymowska I, Kruczak K, Zwolska Z, Augustynowicz-Kopeć E. Gruźlica. Kraków: Medycyna Praktyczna; 2021, pp. 811-830.
13.
Ata F, Magboul HMB, Toba HAA, Alfar H, Al Bozom A, Murshed K, Zahid M. Rifampin-induced acute kidney injury and hemolysis: a case report and literature review of a rare condition. Clin Case Rep 2022; 10: e6780. DOI: 10.1002/ccr3.6780.
14.
Wearne N, Davidson B, Blockman M, Swart A, Jones ES. HIV, drugs and the kidney. Drugs Context 2020; 9: 2019-11-1. DOI: 10.7573/dic.2019-11-1.
15.
Wedajo S, Degu G, Deribew A, Ambaw F. The role of health facility and individual level characteristics on medication adherence among PLHIV on second-line antiretroviral therapy in Northeast Ethiopia: use of multi-level model. AIDS Res Ther 2022; 19: 17. DOI: 10.1186/s12981-022-00441-8.
16.
Khanna N, Nüesch R, Buitrago-Tellez C, Battegay M, Hirsch HH. Hearing loss after discontinuing secondary prophylaxis for cryptococcal meningitis: relapse or immune reconstitution? Infection 2006; 34: 163-168.
17.
Hamidi O, Maroufizadeh S, Poorolajal J, Azimi T, Amini P. Identifying important risk factors for survival of HIV-infected patients using censored quantile regression. HIV AIDS Rev 2023; 22: 19-24.